- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2011-04
2016-01
2016-08
182
NCT02209415
Odense University Hospital
Odense University Hospital
INTERVENTIONAL
EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer
Follow-up after successful operative treatment of cancer in the esophagus, stomach or pancreas in order to detect recurrent disease is a controversial topic. This is because the methods and the consequence of following these patients is unknown. Therefore the investigators will randomize these patients in to two groups: 1. One group of patients will be offered visits with a specialist surgeon in a outpatient setting for a clinical evaluation every 3,6,9,12,18 and 24 months after surgery, as is the current standard at our department. 2. The other group will be offered Endoscopic UltraSound, EUS, and PET/CT with the same intervals as the first group.
N/A
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2011-11-28 | N/A | 2014-08-04 |
2014-08-04 | N/A | 2014-08-05 |
2014-08-05 | N/A | 2014-08 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
Diagnostic
Allocation:
Randomized
Interventional Model:
Parallel
Masking:
None
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| ACTIVE_COMPARATOR: Standard outpatient follow-up Outpatient clinic visits 3,6,9,12,18 and 24 mths after surgery | BEHAVIORAL: standard follow-up
|
| EXPERIMENTAL: Intervention PET/CT and EUS PET/CT and EUS at 3,6,9,12,18 and 24 months after surgery | PROCEDURE: PET/CT and EUS
|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Number of patients eligible for treatment | Does early detection of recurrent disease translate in to more patients being eligible for oncologic treatment? | 2 years |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
18 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
